Iron, infections, and anemia of inflammation

被引:297
作者
Jurado, RL [1 ]
机构
[1] EMORY UNIV, SCH MED, DEPT MED, ATLANTA, GA 30322 USA
关键词
D O I
10.1086/515549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Iron is essential to all microorganisms. To obtain iron from the very low concentrations present in their environment, microorganisms have developed sophisticated mechanisms such as the siderophore system. As a primitive defense mechanism, humans have developed mechanisms to withhold iron from microorganisms. Iron-binding proteins such as transferrin, ferritin, and lactoferrin have a central role in human ferrokinetics. These iron-binding proteins also participate in the process of decreasing iron availability for the microorganisms. They do so by decreasing iron reutilization. Anemia of inflammation (previously called anemia of chronic disease) is seen in the setting of infectious, inflammatory, and neoplastic diseases. It results, in part, from changes in the intracellular metabolism of iron. Alterations of iron physiology seen in many clinical circumstances make excess iron available to microorganisms, thus enhancing their pathogenicity, Understanding the molecular basis of iron withholding by the human host, both in the absence of and during infection, and that of iron acquisition by microorganisms may provide us with new and innovative antimicrobial agents and vaccines.
引用
收藏
页码:888 / 895
页数:8
相关论文
共 103 条
[91]   PHASE-I TRIAL OF RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS [J].
VADHANRAJ, S ;
ALKATIB, A ;
BHALLA, R ;
PELUS, L ;
NATHAN, CF ;
SHERWIN, SA ;
OETTGEN, HF ;
KROWN, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :137-146
[92]   MULTIPLE LIVER-ABSCESSES DUE TO YERSINIA-ENTEROCOLITICA DISCLOSES PRIMARY HEMOCHROMATOSIS - 3 CASE-REPORTS AND REVIEW [J].
VADILLO, M ;
CORBELLA, X ;
PAC, V ;
FERNANDEZVILADRICH, P ;
PUJOL, R .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) :938-941
[93]   IRON ACQUISITION AND THE PATHOGENESIS OF MENINGOCOCCAL AND GONOCOCCAL DISEASE [J].
VANPUTTEN, JPM .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1990, 179 (06) :289-295
[94]   MUCORMYCOSIS IN DEFEROXAMINE-TREATED PATIENTS ON DIALYSIS [J].
VEIS, JH ;
CONTIGUGLIA, R ;
KLEIN, M ;
MISHELL, J ;
ALFREY, AC ;
SHAPIRO, JI .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) :258-258
[95]   IRON-CHELATING AGENTS IN NON-IRON OVERLOAD CONDITIONS [J].
VOEST, EE ;
VREUGDENHIL, G ;
MARX, JJM .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (06) :490-499
[96]   SERUM LEVEL OF ERYTHROPOIETIN IN ANEMIAS ASSOCIATED WITH CHRONIC INFECTION, MALIGNANCY, AND PRIMARY HEMATOPOIETIC DISEASE [J].
WARD, HP ;
KURNICK, JE ;
PISARCZYK, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (02) :332-+
[97]   IMPAIRED PHAGOCYTIC-ACTIVITY OF NEUTROPHILS IN PATIENTS RECEIVING HEMODIALYSIS - THE CRITICAL ROLE OF IRON OVERLOAD [J].
WATERLOT, Y ;
CANTINIEAUX, B ;
HARIGAMULLER, C ;
DEMAERTELAERELAURENT, E ;
VANHERWEGHEM, JL ;
FONDU, P .
BRITISH MEDICAL JOURNAL, 1985, 291 (6494) :501-504
[98]   IRON AND INFECTION [J].
WEINBERG, ED .
MICROBIOLOGICAL REVIEWS, 1978, 42 (01) :45-66
[99]   IRON WITHHOLDING - A DEFENSE AGAINST INFECTION AND NEOPLASIA [J].
WEINBERG, ED .
PHYSIOLOGICAL REVIEWS, 1984, 64 (01) :65-102
[100]   FATAL RHIZOPUS INFECTIONS IN HEMODIALYSIS-PATIENTS RECEIVING DEFEROXAMINE [J].
WINDUS, DW ;
STOKES, TJ ;
JULIAN, BA ;
FENVES, AZ .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :678-680